According to T2 Biosystems 's latest financial reports the company's current earnings (TTM) are -$44.74 M. In 2022 the company made an earning of -$55.92 M a decrease over its 2021 earnings that were of -$42.48 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$44.74 M | -20% |
2022 | -$55.92 M | 31.65% |
2021 | -$42.48 M | 2.9% |
2020 | -$41.28 M | -20.09% |
2019 | -$51.66 M | 16.16% |
2018 | -$44.48 M | -16.91% |
2017 | -$53.53 M | 5.55% |
2016 | -$50.71 M | 17.04% |
2015 | -$43.33 M | 41.26% |
2014 | -$30.67 M | 51.78% |
2013 | -$20.21 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Aldeyra Therapeutics
ALDX | -$35.48 M | -20.71% | ๐บ๐ธ USA |
CareDx CDNA | -$0.11 B | 134.15% | ๐บ๐ธ USA |